Compare Pfizer with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TORRENT PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER TORRENT PHARMA PFIZER/
TORRENT PHARMA
 
P/E (TTM) x 36.5 53.7 67.8% View Chart
P/BV x 6.2 6.4 95.6% View Chart
Dividend Yield % 0.6 0.8 69.8%  

Financials

 PFIZER   TORRENT PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
TORRENT PHARMA
Mar-18
PFIZER/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3,8401,550 247.7%   
Low Rs2,0801,144 181.9%   
Sales per share (Unadj.) Rs455.0354.7 128.3%  
Earnings per share (Unadj.) Rs93.840.1 234.0%  
Cash flow per share (Unadj.) Rs109.464.2 170.3%  
Dividends per share (Unadj.) Rs22.5014.00 160.7%  
Dividend yield (eoy) %0.81.0 73.1%  
Book value per share (Unadj.) Rs658.2273.1 241.0%  
Shares outstanding (eoy) m45.75169.22 27.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.53.8 171.3%   
Avg P/E ratio x31.633.6 93.9%  
P/CF ratio (eoy) x27.121.0 129.0%  
Price / Book Value ratio x4.54.9 91.2%  
Dividend payout %24.034.9 68.7%   
Avg Mkt Cap Rs m135,420227,897 59.4%   
No. of employees `0002.614.7 17.9%   
Total wages/salary Rs m3,23811,353 28.5%   
Avg. sales/employee Rs Th7,911.44,083.0 193.8%   
Avg. wages/employee Rs Th1,230.9772.3 159.4%   
Avg. net profit/employee Rs Th1,630.7461.3 353.5%   
INCOME DATA
Net Sales Rs m20,81560,021 34.7%  
Other income Rs m1,6742,988 56.0%   
Total revenues Rs m22,48963,009 35.7%   
Gross profit Rs m5,71213,493 42.3%  
Depreciation Rs m7144,086 17.5%   
Interest Rs m733,085 2.4%   
Profit before tax Rs m6,5999,310 70.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3092,529 91.3%   
Profit after tax Rs m4,2916,781 63.3%  
Gross profit margin %27.422.5 122.1%  
Effective tax rate %35.027.2 128.8%   
Net profit margin %20.611.3 182.4%  
BALANCE SHEET DATA
Current assets Rs m27,16752,623 51.6%   
Current liabilities Rs m8,91752,022 17.1%   
Net working cap to sales %87.71.0 8,748.8%  
Current ratio x3.01.0 301.2%  
Inventory Days Days68120 56.7%  
Debtors Days Days3076 39.5%  
Net fixed assets Rs m8,86285,016 10.4%   
Share capital Rs m458846 54.1%   
"Free" reserves Rs m29,65645,376 65.4%   
Net worth Rs m30,11346,222 65.1%   
Long term debt Rs m2541,115 0.1%   
Total assets Rs m39,400142,432 27.7%  
Interest coverage x91.54.0 2,277.8%   
Debt to equity ratio x00.9 0.1%  
Sales to assets ratio x0.50.4 125.4%   
Return on assets %11.16.9 159.9%  
Return on equity %14.214.7 97.1%  
Return on capital %22.114.2 156.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42814,580 2.9%   
Fx outflow Rs m7863,600 21.8%   
Net fx Rs m-35810,980 -3.3%   
CASH FLOW
From Operations Rs m9788,942 10.9%  
From Investments Rs m351-47,070 -0.7%  
From Financial Activity Rs m-1,09934,174 -3.2%  
Net Cashflow Rs m231-3,655 -6.3%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 7.0 106.8%  
FIIs % 4.9 12.6 38.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 8.8 269.3%  
Shareholders   85,207 26,511 321.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   FULFORD INDIA  SUVEN LIFESCIENCES  CIPLA  WOCKHARDT  VENUS REMEDIES  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

CSB Bank IPO, October Passenger Vehicle Sales, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets witnessed buying interest during closing hours and ended on a positive note.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 19, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS